Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity

REFERENCES

• Arteaga, C. L., M. D. Johnson, G. Todderud, R. J. Coffey, G. Carpenter, and D. L. Page. 1991. Elevated content of the tyrosine kinase substrate phospholipase C-γ in primary human breast carcinoma. Proc. Natl. Acad. Sci. USA 88:10435–10439.
   PubMed Web of Science ®Google Scholar
• Bargman, C. I., M.-C. Hung, and R. A. Weinberg. 1986. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature (London) 319:226–230.
   PubMedGoogle Scholar
• Bargman, C. I., M.-C. Hung, and R. A. Weinberg. 1986. Multiple independent activation of neu oncogene by a point mutation altering the transmembrane domain of pl85. Cell 45:649–657.
   PubMedGoogle Scholar
• Bargmann, C. I., and R. Weinberg. 1988. Oncogene activation of the new-encoded receptor protein by point mutation and deletion. EMBO J. 7:2043–2052.
   PubMed Web of Science ®Google Scholar
• Cardiff, R. D., and W. J. Muller. 1993. Transgenic mouse models of mammary tumorigenesis. Cancer Surv. 16:97–113.
   PubMedGoogle Scholar
• Cheng, H.-C., H. Nishio, O. Hatase, S. Ralph, and J. H. Wang. 1992. A synthetic peptide derived from p34cdc-2 is a specific and efficient substrate of src-family tyrosine kinases. J. Biol. Chem. 267:9248–9257.
   PubMedGoogle Scholar
• Courtneidge, S. A., R. Dhand, D. Pilat, G. M. Twamely, M. D. Waterfiel, and M. Roussel. 1993. Activation of src family kinases by colony stimulating factor-1, and their association with its receptor. EMBO J. 12:943–950.
   PubMed Web of Science ®Google Scholar
• Coussens, L., T. L. Yang-Feng, Y. Liao, E. Chen, A. Gray, J. McGrath, P. H. Seeburg, T. A. Liberman, J. Schlessinger, U. Francke, A. Levinson, and A. Ullrich. 1985. Tyrosine kinase receptor with extensive homology EGF receptor shares chromosomal location with neu oncogene. Science 230:1132–1139.
   PubMed Web of Science ®Google Scholar
• DiFore, P. P., J. H. Pierce, M. H. Krens, O. Segatto, C. R. King, and S. A. Aaronson. 1987. erbB-2 is a potent oncogene when overexpressed in NIH-3T3 cells. Science 237:178–182.
   PubMedGoogle Scholar
• DiMarco, E., J. H. Pierce, C. L. Kingslry, and P. P. DiFiore. 1990. Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the rat neu gene. Mol. Cell. Biol. 10:3247–3252.
   PubMedGoogle Scholar
• Fazioli, F., U. Kim, S. G. Rhee, C. J. Molloy, O. Segatto, and P. P. DiFiore. 1991. The erbB-2 mitogenic signalling pathway: tyrosine phosphorylation of phospholipase C-y and GTPase-activating protein does not correlate with erbB-2 mitogenic potency. Mol. Cell. Biol. 11:2040–2048.
   PubMed Web of Science ®Google Scholar
• Gullick, W. J., S. B. Love, C. Wright, D. M. Barnes, B. Gutterson, A. L. Harris, and D. G. Altman. 1991. c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br. J. Cancer 63:434–438.
   PubMed Web of Science ®Google Scholar
• Guy, C. T., R. D. Cardiff, and W. J. Muller. 1992. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12:954–961.
   PubMed Web of Science ®Google Scholar
• Guy, C. T., S. K. Muthuswamy, R. D. Cardiff, and W. J. Muller. Unpublished observations.
   Google Scholar
• Guy, C. T., M. A. Webster, M. Schaller, T. J. Parson, R. D. Cardiff, and W. J. Muller. 1992. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA 89:10578–10582.
   PubMed Web of Science ®Google Scholar
• Hudziak, R., J. Schlessinger, and A. Ullrich. 1987. Increased expression of the putative growth factor receptor pl85HER-2 causes transformation and tumorigenesis in NIH-3T3 cells. Proc. Natl. Acad. Sci. USA 84:7159–7163.
   PubMed Web of Science ®Google Scholar
• Jacobs, C., and H. Rubsamen. 1983. Expression of pp60c-src protein kinase in adult and fetal human tissues: high activities in some sarcomas and mammary carcinomas. Cancer Res. 43:1696–1702.
   PubMed Web of Science ®Google Scholar
• King, C. R., M. H. Kraus, and S. A. Aaronson. 1985. Amplification of a novel v-erbB related gene in human mammary carcinoma. Science 229:974–976.
   PubMed Web of Science ®Google Scholar
• Koch, C. A., M. F. Moran, D. Anderson, X. Liu, G. Mbamalu, and T. Pawson. 1992. Multiple SH2-mediated interaction in v-src-transformed cells. Mol. Cell. Biol. 12:1366–1374.
   PubMedGoogle Scholar
• Kypta, R. M., Y. Goldberg, E. T. Ulug, and S. A. Courtneidge. 1990. Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell 62:481–492.
   PubMed Web of Science ®Google Scholar
• Muller, W. J., E. Sinn, R. Wallace, P. K. Pattengale, and P. Leder. 1988. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105–115.
   PubMed Web of Science ®Google Scholar
• Muthuswamy, S. K. Unpublished data.
   Google Scholar
• Muthuswamy, S. K., R. D. Cardiff, and W. J. Muller. Unpublished data.
   Google Scholar
• Ottenhoff-Kalff, A. E., G. Rijksen, E. A. C. M. van Beurden, A. Hennipman, A. A. Michels, and G. E. J. Staal. 1992. Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product. Cancer Res. 52:4773–4778.
   PubMed Web of Science ®Google Scholar
• Paterson, M. C., K. D. Dietrich, J. Danyluk, A. H. Paterson, A. W. Lees, N. Jamil, J. Hanson, H. Jenkins, B. E. Krause, W. A. McBlain, D. J. Slamon, and R. M. Fourney. 1991. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Cancer Res. 51:556–567.
   PubMed Web of Science ®Google Scholar
• Rosen, N., J. B. Bolen, A. M. Schwartz, P. Cohen, V. DeSeau, and M. A. Israel. 1986. Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues. J. Biol. Chem. 261:13754–13759.
   PubMed Web of Science ®Google Scholar
• Roussel, M. F., J. L. Cleveland, S. A. Shutleff, and C. J. Sherr. 1992. Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling. Nature (London) 325:549–552.
   Google Scholar
• Schechter, A. L., M. C. Hung, O. Vaidyanathan, W. A. Weinberg, F. L. Yang-Feng, U. Francke, A. Ullrich, and L. Coussens. 1985. The neu gene: an erbB homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 229:976–978.
   PubMed Web of Science ®Google Scholar
• Segatto, O., F. Lonardo, K. Helin, D. Wexler, F. Fazioli, S. G. Rhee, and P. P. DiFiore. 1992. erbB-2 autophosphorylation is required for mitogenic action and high affinity substrate cou pling. Oncogene 7:1339–1346.
   PubMedGoogle Scholar
• Semba, K., N. Kamata, K. Toyoshima, and T. Yamamoto. 1985. A v-erbB-related protooncogene, c-erbB-2, is distinct from c-erbB-1/epidermal growth factor receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc. Natl. Acad. Sci. USA 82:6497–6501.
   PubMed Web of Science ®Google Scholar
• Slamon, D. J., G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire. 1987. Human breast cancer: correlation of relapse and survival with amplification of Her-2/neu oncogene. Science 235:177–182.
   PubMed Web of Science ®Google Scholar
• Slamon, D. J., W. Godolphin, L. A. Jones, J. A. Holt, S. G. Wong, D. E. Keith, W. J. Levin, S. G. Styart, J. Udove, A. Ullrich, and M. F. Press. 1989. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science 244:707–712.
   PubMed Web of Science ®Google Scholar
• Smith, D. B., and K. S. Johnson. 1991. Single-step purification of polypeptides in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31–40.
   Google Scholar
• Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Schaffhausen, and L. Cantley. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 77:767–778.
   Google Scholar
• Soriano, P., C. Montgomery, R. Geske, and A. Bradley. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693–702.
   PubMed Web of Science ®Google Scholar
• Stewart, T. A., P. K. Pattengale, and P. Leder. 1984. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38:627–637.
   PubMed Web of Science ®Google Scholar
• Twamely, G. M., R. M. Kypta, B. Hall, and S. A. Courtneidge. 1992. Association of fyn with the activated platelet growth factor receptor: requirements for binding and phosphorylation. Oncogene 7:1893–1901.
   PubMedGoogle Scholar
• Twamley-Stein, G. M., R. Papperkok, W. Ansorge, S. A. Courtneidge. 1993. The Src family tyrosine kinase are required for platelet derived growth factor mediated signal transduction in NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 90:7696–7700.
   PubMed Web of Science ®Google Scholar
• Van Louhuizen, M., S. Verbeek, P. Krimpenfort, J. Domen, C. Saris, T. Radaszkiewicz, and A. Berns. 1989. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus induced tumors. Cell 56:673–682.
   PubMedGoogle Scholar
• Van Louhuizen, M., S. Verbeek, B. Scheyen, H. Vandergulden, and A. Berns. 1989. Identification of cooperating oncogenes in ε-μ-myc transgenic mice by provirus tagging. Cell 65:737–752.
   Google Scholar
• Vogel, W., R. Lammers, J. Huang, and A. Ullrich. 1993. Activation of a tyrosine phosphatase by tyrosine phosphorylation. Science 259:1611–1614.
   PubMed Web of Science ®Google Scholar
• Yamamoto, T., S. Ikawa, T. Akiyama, K. Semba, N. Nomura, N. Miyajima, T. Saito, and K. Toyoshima. 1986. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor. Nature (London) 319:230–234.
   PubMed Web of Science ®Google Scholar